Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis

Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis

US Patent 11980621 · Granted May 14, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the treatment of adenomyosis and rectovaginal endom2025
Compositions and methods for the treatment of adenomyosis and rectovaginal endom2025
Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine f2023
Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine f2023
Compositions and methods for delaying the incidence of labor2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2020
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2020
Method for treating gynecological diseases2019
Method for treating gynecological diseases2019
Treatment of pain associated with dislocation of endometrium2019